|Tested species reactivity||Goat|
|Published species reactivity||Not Applicable|
|Host / Isotype||Rabbit / IgG|
|Storage buffer||PBS, pH 7.4, with 4mg/ml BSA, 40% glycerol|
|Contains||0.1% Proclin 300|
|Storage Conditions||4° C|
|Antibody Form||Whole Antibody|
|Tested Applications||Dilution *|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
Anti-Goat secondary antibodies are affinity-purified antibodies with well-characterized specificity for goat immunoglobulins and are useful in the detection, sorting or purification of its specified target. Secondary antibodies offer increased versatility enabling users to use many detection systems (e.g. HRP, AP, fluorescence). They can also provide greater sensitivity through signal amplification as multiple secondary antibodies can bind to a single primary antibody. Most commonly, secondary antibodies are generated by immunizing the host animal with a pooled population of immunoglobulins from the target species and can be further purified and modified (i.e. immunoaffinity chromatography, antibody fragmentation, label conjugation, etc.) to generate highly specific reagents.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
|Not Applicable||Not Cited||Higher clusterin immunolabeling and sperm DNA damage levels in hypertensive men compared with controls.||Muciaccia B,Pensini S,Culasso F,Padula F,Paoli D,Gandini L,Di Veroli C,Bianchini G,Stefanini M,D'Agostino A||Human reproduction (Oxford, England) (27:2267)||2012|
Role of dorsal vagal motor nucleus orexin-receptor-1 in glycemic responses to acute versus repeated insulin administration.
61-1620 was used in western blot to test if recurrent insulin-induced hypoglycemia-associated patterns of orexin-A neurotransmission and orexin-receptor-1 expression within the dorsal vagal motor nucleus correlate with exacerbated hypoglycemic and impair
|Paranjape S,Vavaiya K,Kale A,Briski K||Neuropeptides (41:111)||2007|
|Not Applicable||Not Cited||
Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells.
61-1620 was used in ELISA to study how cutaneous fatty acid-binding protein induces metastasis.
|Jing C,Beesley C,Foster CS,Chen H,Rudland PS,West DC,Fujii H,Smith PH,Ke Y||Cancer research (61:4357)||2001|
|Not Applicable||Not Cited||
Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells.
61-1620 was used in ELISA to assess the role of VEGF in facilitating metastasis of prostate cancer via stimulating angiogenesis.
|Chen HJ,Treweeke AT,Ke YQ,West DC,Toh CH||British journal of cancer (82:1694)||2000|